Sangui BioTech International, Inc. ("SGBI") is a holding company the shares of which are being traded on the OTCQB marketplace and the OTC markets of the Berlin and Hamburg-Hannover stock exchanges. Its purpose is to provide financing and access to the capital markets for the enterprises of the Sangui group. SGBI has been a reporting company since 2000 and is current in its filings with the SEC.
Wound Market Research by Panaceus
(also available in German language)

"Motivations and goals following the acquisition of SastoMed GmbH by the Mölnlycke Group"